JP2017536343A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536343A5
JP2017536343A5 JP2017518929A JP2017518929A JP2017536343A5 JP 2017536343 A5 JP2017536343 A5 JP 2017536343A5 JP 2017518929 A JP2017518929 A JP 2017518929A JP 2017518929 A JP2017518929 A JP 2017518929A JP 2017536343 A5 JP2017536343 A5 JP 2017536343A5
Authority
JP
Japan
Prior art keywords
amino
carboxy
butanoyl
ethoxy
glp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017518929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536343A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073372 external-priority patent/WO2016055610A1/en
Publication of JP2017536343A publication Critical patent/JP2017536343A/ja
Publication of JP2017536343A5 publication Critical patent/JP2017536343A5/ja
Withdrawn legal-status Critical Current

Links

JP2017518929A 2014-10-10 2015-10-09 安定したglp−1ベースのglp−1/グルカゴン受容体コアゴニスト Withdrawn JP2017536343A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14188421.3 2014-10-10
EP14188421 2014-10-10
PCT/EP2015/073372 WO2016055610A1 (en) 2014-10-10 2015-10-09 Stable glp-1 based glp-1/glucagon receptor co-agonists

Publications (2)

Publication Number Publication Date
JP2017536343A JP2017536343A (ja) 2017-12-07
JP2017536343A5 true JP2017536343A5 (cg-RX-API-DMAC7.html) 2018-11-08

Family

ID=51663097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518929A Withdrawn JP2017536343A (ja) 2014-10-10 2015-10-09 安定したglp−1ベースのglp−1/グルカゴン受容体コアゴニスト

Country Status (7)

Country Link
US (1) US9988430B2 (cg-RX-API-DMAC7.html)
EP (1) EP3204408B1 (cg-RX-API-DMAC7.html)
JP (1) JP2017536343A (cg-RX-API-DMAC7.html)
CN (1) CN107108713A (cg-RX-API-DMAC7.html)
ES (1) ES2805326T3 (cg-RX-API-DMAC7.html)
TW (1) TW201629095A (cg-RX-API-DMAC7.html)
WO (1) WO2016055610A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
CA2895875A1 (en) 2012-12-21 2014-06-26 Sanofi Exendin-4 derivatives
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
AR105284A1 (es) 2015-07-10 2017-09-20 Sanofi Sa Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
CN109475568A (zh) 2016-05-06 2019-03-15 Ionis制药公司 Glp-1受体配体部分缀合的寡核苷酸及其用途
BR112020000373B1 (pt) * 2017-07-13 2022-05-10 Fuji Oil Holdings Inc Peptídeos, agentes que conferem sabor encorpado a um alimento e métodos para produzir um alimento e para para conferir um sabor encorpado a um alimento
JP7604666B2 (ja) 2021-01-20 2024-12-23 バイキング・セラピューティクス・インコーポレイテッド 代謝及び肝臓障害の処置のための組成物及び方法
WO2023044290A1 (en) 2021-09-15 2023-03-23 Viking Therapeutics, Inc. Compositions and methods for the treatment of metabolic and liver disorders
CN115490760B (zh) * 2022-07-04 2023-04-14 北京惠之衡生物科技有限公司 一种glp-1受体和gcg受体共激动多肽衍生物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406384T1 (de) * 2000-12-07 2008-09-15 Lilly Co Eli Glp-1 fusion proteine
EP2068910A2 (en) * 2006-08-04 2009-06-17 Amylin Pharmaceuticals, Inc. Use of exendins and exendin agonists and glp-1 receptor agonists for altering lipoprotein particle size and subclass composition
WO2009030738A1 (en) * 2007-09-05 2009-03-12 Novo Nordisk A/S Glucagon-like peptide-1 derivatives and their pharmaceutical use
WO2009030771A1 (en) 2007-09-05 2009-03-12 Novo Nordisk A/S Peptides derivatized with a-b-c-d- and their therapeutical use
CN102075337A (zh) 2009-11-20 2011-05-25 腾讯科技(深圳)有限公司 一种即时通信消息显示方法和相关装置
US8703701B2 (en) 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
MX342409B (es) 2010-01-20 2016-09-28 Zealand Pharma As Tratamiento de enfermedades cardiacas.
AU2011231503C1 (en) * 2010-03-26 2016-03-03 Novo Nordisk A/S Novel glucagon analogues
AP2013006671A0 (en) * 2010-06-24 2013-01-31 Zealand Pharma As Glucagon analogues
EP3225631B1 (en) 2011-04-12 2019-01-09 Novo Nordisk A/S Double-acylated glp-1 derivatives
TWI596110B (zh) * 2011-09-23 2017-08-21 諾佛 儂迪克股份有限公司 新穎升糖素類似物
JP2017509603A (ja) * 2014-02-18 2017-04-06 ノヴォ ノルディスク アー/エス 安定なグルカゴン類似体及び低血糖症の処置のための使用

Similar Documents

Publication Publication Date Title
JP2017536343A5 (cg-RX-API-DMAC7.html)
JP2016526012A5 (cg-RX-API-DMAC7.html)
RU2015146600A (ru) Стабильные совместные агонисты рецептора глюкагоноподобного пептида-1/глюкагона пролонгированного действия для медицинского применения
JP2012529463A5 (cg-RX-API-DMAC7.html)
RU2434019C2 (ru) Ацилированные glp-1 соединения
JP6121330B2 (ja) 作用持続時間が増した改変ポリペプチド
JP7095027B2 (ja) 新規のアミリン及びカルシトニン受容体アゴニスト
JP2016531156A5 (cg-RX-API-DMAC7.html)
JP2008533105A5 (cg-RX-API-DMAC7.html)
KR102302634B1 (ko) 변형된 치료제 및 이의 조성물
KR102455171B1 (ko) 변형된 치료제, 스테이플드 펩티드 지질 접합체, 및 이의 조성물
RU2550696C2 (ru) Основанные на амидах пролекарства пептидов глюкагонового надсемейства
RU2007134155A (ru) Glp-1 соединения с увеличенным временем полужизни
JP2018505146A5 (cg-RX-API-DMAC7.html)
JP2013543853A5 (cg-RX-API-DMAC7.html)
JP2013533849A5 (cg-RX-API-DMAC7.html)
JP2012506402A5 (cg-RX-API-DMAC7.html)
CA2797089A1 (en) Glucagon superfamily peptides exhibiting g protein-coupled receptor activity
JP2011524420A5 (cg-RX-API-DMAC7.html)
JP2016500682A5 (cg-RX-API-DMAC7.html)
JP2014510739A5 (cg-RX-API-DMAC7.html)
JP2014527975A5 (cg-RX-API-DMAC7.html)
JP2013518115A5 (cg-RX-API-DMAC7.html)
JP2011502159A5 (cg-RX-API-DMAC7.html)
JP2012518035A5 (cg-RX-API-DMAC7.html)